A women’s rights group and a legislator urged the government to establish an official reporting mechanism for suspected adverse reactions to the human papillomavirus (HPV) vaccination, as government-funded vaccinations are to begin soon.
The Health Promotion Administration in February announced that government-funded HPV vaccinations would be given to seventh-grade girls from November, and that an estimated 100,000 students would be vaccinated each year.
HPV is mainly transmitted through sexual contact and the vaccine protects against several types of HPV, including two high-risk strains that cause nearly 70 percent of cervical cancers and precancerous cervical lesions, the administration said.
In June, two Control Yuan members launched an investigation into the policy, saying that it seemed to lack enough risk evaluations and supporting measures and that a verification mechanism was needed to test the vaccine’s effectiveness.
Taiwan Women’s Link chairwoman Huang Sue-ying (黃淑英) and Democratic Progressive Party Legislator Lin Shu-fen (林淑芬) on Friday said the government should establish a reporting mechanism to handle cases of suspected adverse reactions to the vaccine.
They presented the case of a woman in her late 30s surnamed Chen who said that she suffered serious adverse reactions when she was vaccinated at the recommendation of her doctor after giving birth to her second child in February.
Chen said she experienced numbness, chest pain, weakness on one side of her body and visual impairment, adding that she was diagnosed with a central nervous system disorder called neuromyelitis optica, which needs long-term therapy.
About 800,000 doses of the HPV vaccine were administered in Taiwan over the past decade, and 167 suspected adverse reactions were reported, Food and Drug Administration (FDA) official Chen Ko-hsin (陳可欣) said, but added that this was the first reported case of neuromyelitis optica.
“Pharmaceutical companies are required to report to the FDA all suspected adverse reactions in the first five years after a new drug is launched on the market,” she said.
Although most vaccines are considered safe, the government must still establish a reporting mechanism to handle cases of adverse reactions, Lin said.
Alain Robert, known as the "French Spider-Man," praised Alex Honnold as exceptionally well-prepared after the US climber completed a free solo ascent of Taipei 101 yesterday. Robert said Honnold's ascent of the 508m-tall skyscraper in just more than one-and-a-half hours without using safety ropes or equipment was a remarkable achievement. "This is my life," he said in an interview conducted in French, adding that he liked the feeling of being "on the edge of danger." The 63-year-old Frenchman climbed Taipei 101 using ropes in December 2004, taking about four hours to reach the top. On a one-to-10 scale of difficulty, Robert said Taipei 101
Nipah virus infection is to be officially listed as a category 5 notifiable infectious disease in Taiwan in March, while clinical treatment guidelines are being formulated, the Centers for Disease Control (CDC) said yesterday. With Nipah infections being reported in other countries and considering its relatively high fatality rate, the centers on Jan. 16 announced that it would be listed as a notifiable infectious disease to bolster the nation’s systematic early warning system and increase public awareness, the CDC said. Bangladesh reported four fatal cases last year in separate districts, with three linked to raw date palm sap consumption, CDC Epidemic Intelligence
US climber Alex Honnold left Taiwan this morning a day after completing a free-solo ascent of Taipei 101, a feat that drew cheers from onlookers and gained widespread international attention. Honnold yesterday scaled the 101-story skyscraper without a rope or safety harness. The climb — the highest urban free-solo ascent ever attempted — took just more than 90 minutes and was streamed live on Netflix. It was covered by major international news outlets including CNN, the New York Times, the Guardian and the Wall Street Journal. As Honnold prepared to leave Taiwan today, he attracted a crowd when he and his wife, Sanni,
Taiwanese and US defense groups are collaborating to introduce deployable, semi-autonomous manufacturing systems for drones and components in a boost to the nation’s supply chain resilience. Taiwan’s G-Tech Optroelectronics Corp subsidiary GTOC and the US’ Aerkomm Inc on Friday announced an agreement with fellow US-based Firestorm Lab to adopt the latter’s xCell, a technology featuring 3D printers fitted in 6.1m container units. The systems enable aerial platforms and parts to be produced in high volumes from dispersed nodes capable of rapid redeployment, to minimize the risk of enemy strikes and to meet field requirements, they said. Firestorm chief technology officer Ian Muceus said
RSS